610. Voriconazole versus isavuconazole in patients with invasive aspergillosis: a retrospective study in a medically insured population across the United States

BACKGROUND: Isavuconazole demonstrated similar outcomes but improved tolerability versus voriconazole (VCZ) for invasive aspergillosis (IA). Despite this, VCZ remains the treatment of choice for IA. Therefore, we compared outcomes between patients with IA treated with VCZ versus isavuconazole (ISA)....

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Sophea, Stoudenmire, Laura Leigh, Zhan, Duna, Chen, Xianyan, Henao Martínez, Andrés F, Chastain, Daniel B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677192/
http://dx.doi.org/10.1093/ofid/ofad500.676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677192/
http://dx.doi.org/10.1093/ofid/ofad500.676

Ejemplares similares